P

Inventor

ANAND NEEL K

US25 patents
⚠️ This page may combine multiple inventors who share the name “ANAND NEEL K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEKTAR THERAPEUTICS

18 patents
US10434181B2Oct 8, 2019

Oligomer-containing benzamide-based compounds

NEKTAR THERAPEUTICS1 citations73
US9815824B2Nov 14, 2017

Kappa opioid agonists and uses thereof

NEKTAR THERAPEUTICS4 citations72
US11744898B2Sep 5, 2023

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

NEKTAR THERAPEUTICS2 citations71
US10322107B2Jun 18, 2019

N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

NEKTAR THERAPEUTICS3 citations71
US10081602B2Sep 25, 2018

Opioid agonists and uses thereof

NEKTAR THERAPEUTICS2 citations71
US10189859B2Jan 29, 2019

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

NEKTAR THERAPEUTICS2 citations70
US9375486B2Jun 28, 2016

Oligomer-containing benzamide-based compounds

NEKTAR THERAPEUTICS1 citations63
US11111214B2Sep 7, 2021

Kappa opioid agonists and uses thereof

NEKTAR THERAPEUTICS0 citations62
US12214045B2Feb 4, 2025

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

NEKTAR THERAPEUTICS0 citations61
US11241415B2Feb 8, 2022

N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor

NEKTAR THERAPEUTICS0 citations61
US12325708B2Jun 10, 2025

Adenosine 2 receptor antagonists

NEKTAR THERAPEUTICS0 citations59
US12054553B2Aug 6, 2024

Immunotherapeutic tumor treatment method

NEKTAR THERAPEUTICS0 citations58
US12030940B2Jul 9, 2024

Immunotherapeutic tumor treatment method

NEKTAR THERAPEUTICS0 citations55
US9937266B2Apr 10, 2018

Oligomer-containing benzamide-based compounds

NEKTAR THERAPEUTICS0 citations52
US10407416B2Sep 10, 2019

Kappa opioid agonists and uses thereof

NEKTAR THERAPEUTICS0 citations51
US10865186B2Dec 15, 2020

Opioid agonists and uses thereof

NEKTAR THERAPEUTICS0 citations50
US10766864B2Sep 8, 2020

Morphinan derivatives for the treatment of neuropathic pain

NEKTAR THERAPEUTICS0 citations50
US10844076B2Nov 24, 2020

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

NEKTAR THERAPEUTICS0 citations49

SYMPHONY EVOLUTION INC

3 patents

RICE KENNETH D

2 patents

ANAND NEEL K

1 patent

NEKTAR THERAPEUTICS (INDIA) PVT LTD

1 patent